Cargando…
Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022
Cardiovascular disease (CVD) is the leading cause of death around the world, warranting an increasing number of studies for its treatment. Among all of its therapeutical strategies, engineered exosomes are attracting growing attention due to their excellent biocompatibility, non-immunogenicity, and...
Autores principales: | Zhang, Xiao, Yang, Zijiang, Jiang, Jizong, Tang, Ming, Guan, Longfei, Lee, Hangil, Wang, Hongyun, Xu, Jiahong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415707/ https://www.ncbi.nlm.nih.gov/pubmed/37576273 http://dx.doi.org/10.1016/j.heliyon.2023.e18809 |
Ejemplares similares
-
Corrigendum to “Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022” [Heliyon 9(8) (August 2023) e18809]
por: Zhang, Xiao, et al.
Publicado: (2023) -
Bibliometric and visual analysis in the field of traditional Chinese medicine in cancer from 2002 to 2022
por: Bai, Facheng, et al.
Publicado: (2023) -
Trends in research on dietary behavior and cardiovascular disease from 2002 to 2022: a bibliometric analysis
por: Wang, Jie, et al.
Publicado: (2023) -
Autoimmune pancreatitis: A bibliometric analysis from 2002 to 2022
por: Zhang, Xian-Da, et al.
Publicado: (2023) -
Bibliometric evaluation of publications on inflammasomes in atherosclerosis from 2002 to 2022
por: Tan, Yu, et al.
Publicado: (2023)